Gene · 407037
MIR320A: microRNA 320a
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. MIR320A: microRNA 320a. Genes, record 407037. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/407037
On this page
Gene
Proteins0
Reviewed human proteins whose Swiss-Prot entry states the gene.
None in this release.
Patents0
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
None in this release.
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants826
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | MIR320A papers | Newest fiscal year |
|---|---|---|---|
| P30CA016058 | Cancer Center Support Grant | 9 | 2025 |
| R35GM128753 | Molecular mechanisms for regulating microRNA levels in metazoans | 4 | 2025 |
| P30DK058404 | Molecular and Cellular Basis for Digestive Diseases | 3 | 2025 |
| R01ES004738 | Activated Macrophages and Ozone Toxicity | 3 | 2025 |
| T32ES007148 | Training in Environmental Toxicology | 3 | 2025 |
| U10CA180899 | Children's Oncology Group Statistics and Data Center | 3 | 2025 |
| K12HD000849 | Reproductive Scientist Development Program | 2 | 2025 |
| P01CA214091 | Noncoding RNAs in gamma-Herpesvirus Biology and AIDS Malignancies | 2 | 2025 |
| P01HL116263 | HDL Function in Human Disease | 2 | 2025 |
| P30AG028740 | University of Florida Older Americans Independence Center (OAIC) | 2 | 2025 |
1 to 10 of 826Source NIH's project files
See all 826 nih grantsPapers2,743
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Radiotherapy Reconstitutes the Collapsed miRNome of Progressive Neuroblastoma and Promotes a Favorable Tumor Evolutionary Shift. | Front Biosci (Landmark Ed) | 2026 | 42811996 | PubTator, text mining | PubMed |
| Statement of Retraction: Upregulation of long non-coding RNA NNT-AS1 promotes osteosarcoma progression by inhibiting the tumor suppressive miR-320a. | Cancer Biol Ther | 2026 | 42811790 | PubTator, text mining | PubMed |
| MicroRNA-206 as a Novel Potential Prognostic Biomarker for Distinguishing Philadelphia Chromosome-Positive and Negative ALL Patients. | Int J Hematol Oncol Stem Cell Res | 2026 | 42756346 | PubTator, text mining | PubMed |
| Noncoding RNAs as Prognostic Biomarkers After Myocardial Infarction: A Scoping Review. | J Am Heart Assoc | 2026 | 42622088 | PubTator, text mining | PubMed |
| Differential expression of salivary microRNA associated with keratoconus. | Exp Eye Res | 2026 | 42567395 | PubTator, text mining | PubMed |
| MicroRNA profiles as quality biomarkers in stored blood components: A narrative review. | Vox Sang | 2026 | 42481401 | PubTator, text mining | PubMed |
| Co-g-C3N4 Nanozyme-Based Colorimetric Biosensor for miR-320a Detection in Thyroid-Associated Ophthalmopathy. | J Fluoresc | 2026 | 42455399 | PubTator, text mining | PubMed |
| Circulating microRNAs as diagnostic biomarkers and pathogenic mediators in type 2 diabetic retinopathy: a systematic review. | Acta Diabetol | 2026 | 42455341 | PubTator, text mining | PubMed |
| Co-expressed microRNAs associated with elevated psychometabolic risk phenotype in women during midlife. | Front Endocrinol (Lausanne) | 2026 | 42416907 | PubTator, text mining | PubMed |
| Molecular Protein Interactions and Predictive Pathways as Biomarkers for Enhancing Volleyball Performance: A Narrative Review. | Biomark Insights | 2026 | 42404021 | PubTator, text mining | PubMed |
1 to 10 of 2,743
See all 2,743 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/407037
GET https://conductscience.org/api/genes/v1/407037/grants?page=2